(19)
(11) EP 4 543 488 A2

(12)

(88) Date of publication A3:
25.04.2024

(43) Date of publication:
30.04.2025 Bulletin 2025/18

(21) Application number: 23858335.5

(22) Date of filing: 25.08.2023
(51) International Patent Classification (IPC): 
A61K 39/39(2006.01)
C07K 16/22(2006.01)
C07K 16/32(2006.01)
A61P 37/02(2006.01)
C07K 16/28(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/2827; C07K 2317/569; C07K 2317/22; C07K 2317/92; C07K 2317/24; C07K 16/22; C07K 2317/31; C07K 2317/76; A61K 2039/505; A61K 2039/507; A61P 35/00
(86) International application number:
PCT/US2023/072884
(87) International publication number:
WO 2024/044732 (29.02.2024 Gazette 2024/09)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 25.08.2022 US 202263401086 P

(71) Applicant: Bright Biologics LLC
Lewes, DE 19958 (US)

(72) Inventors:
  • YANG, Ming
    Mountain View, California 93043 (US)
  • ZHONG, Hongyan
    Mountain View, California 94040 (US)
  • LI, Hsieh
    Mountain View, California 94043 (US)
  • GUO, Daniel
    San Jose, California 95132 (US)

(74) Representative: Fish & Richardson P.C. 
Highlight Business Towers Mies-van-der-Rohe-Straße 8
80807 München
80807 München (DE)

   


(54) MULTISPECIFIC ANTIBODIES AND USES THEREOF